Meloxicam Dosage and Treatment for Chronic Back Pain Associated with Spinal Stenosis

First-Line Pharmacological Treatment Options

The American College of Physicians recommends NSAIDs, including meloxicam, as first-line medications for chronic low back pain, including pain associated with spinal stenosis 2
The standard dosing regimen for meloxicam in chronic back pain starts with 7.5 mg once daily, which can be increased to 15 mg once daily if needed for adequate pain control 1

Before prescribing meloxicam, assess cardiovascular and gastrointestinal risk factors as NSAIDs are associated with well-known gastrointestinal, renovascular, and cardiovascular risks 2, 1
Consider co-administration with a proton-pump inhibitor in higher-risk patients to minimize gastrointestinal adverse effects 2, 1
For patients with cardiovascular risk factors, acetaminophen (up to 4g/day) may be preferred over NSAIDs despite being a slightly weaker analgesic 2, 1

If meloxicam provides inadequate pain control, consider adding muscle relaxants for short-term relief, though these are associated with central nervous system adverse effects, primarily sedation 3, 1
For patients with severe, disabling pain not controlled with NSAIDs, opioid analgesics or tramadol may be considered as a third-line option, though they carry substantial risks including aberrant drug-related behavior 2, 3
Non-pharmacological approaches should be considered alongside medication therapy, including exercise therapy, multidisciplinary rehabilitation programs, and spinal manipulation 4

For spinal stenosis specifically, evidence suggests that systemic corticosteroids are not effective, with one trial finding no differences through 12 weeks of follow-up between a 3-week course of prednisone and placebo 5
Recent guidelines strongly recommend against epidural injections for chronic low back pain due to spinal stenosis in the absence of significant radicular symptoms 6, 7

Regular reassessment of pain control and medication effectiveness is essential 1
Monitor for adverse effects, particularly in elderly patients or those with comorbidities 1